145 related articles for article (PubMed ID: 12508674)
1. [Cultural influenza vaccines].
Gendon IuZ
Vopr Virusol; 2002; 47(6):4-11. PubMed ID: 12508674
[TBL] [Abstract][Full Text] [Related]
2. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine.
Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Dorner F
Vaccine; 1998; 16(9-10):960-8. PubMed ID: 9682344
[TBL] [Abstract][Full Text] [Related]
3. Preflucel®: a Vero-cell culture-derived trivalent influenza vaccine.
Chan CY; Tambyah PA
Expert Rev Vaccines; 2012 Jul; 11(7):759-73. PubMed ID: 22913252
[TBL] [Abstract][Full Text] [Related]
4. [Development of a novel influenza vaccine derived from a continuous cell line].
Kistner O; Barrett N; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
ALTEX; 2001; 18(1):50-4. PubMed ID: 11248852
[TBL] [Abstract][Full Text] [Related]
5. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
[TBL] [Abstract][Full Text] [Related]
6. Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines.
Nakowitsch S; Waltenberger AM; Wressnigg N; Ferstl N; Triendl A; Kiefmann B; Montomoli E; Lapini G; Sergeeva M; Muster T; Romanova JR
Biotechnol J; 2014 Mar; 9(3):405-14. PubMed ID: 24323790
[TBL] [Abstract][Full Text] [Related]
7. Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: safety, immunogenicity, and protective efficacy.
Keitel WA
Semin Pediatr Infect Dis; 2002 Apr; 13(2):112-9. PubMed ID: 12122949
[TBL] [Abstract][Full Text] [Related]
8. [Progress in new vaccine strategies against influenza: a review].
Liu Z; Jiang T; Qin E; Ran D; Qin C
Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
[TBL] [Abstract][Full Text] [Related]
9. Development of a Vero cell-derived influenza whole virus vaccine.
Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
Dev Biol Stand; 1999; 98():101-10; discussion 111. PubMed ID: 10494963
[TBL] [Abstract][Full Text] [Related]
10. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
[TBL] [Abstract][Full Text] [Related]
11. Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production.
Montomoli E; Khadang B; Piccirella S; Trombetta C; Mennitto E; Manini I; Stanzani V; Lapini G
Expert Rev Vaccines; 2012 May; 11(5):587-94. PubMed ID: 22827244
[TBL] [Abstract][Full Text] [Related]
12. Continuous cell lines as a production system for influenza vaccines.
Genzel Y; Reichl U
Expert Rev Vaccines; 2009 Dec; 8(12):1681-92. PubMed ID: 19943763
[TBL] [Abstract][Full Text] [Related]
13. A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale production.
Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
Wien Klin Wochenschr; 1999 Mar; 111(5):207-14. PubMed ID: 10226351
[TBL] [Abstract][Full Text] [Related]
14. Influenza virus vaccines in children and their impact on the incidence of otitis media.
Rafei K
Semin Pediatr Infect Dis; 2002 Apr; 13(2):129-33. PubMed ID: 12122951
[TBL] [Abstract][Full Text] [Related]
15. Genetic engineering of live attenuated influenza viruses.
Jin H; Chen Z; Liu J; Kemble G
Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
[TBL] [Abstract][Full Text] [Related]
16. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
17. The future of cell culture-based influenza vaccine production.
Perdue ML; Arnold F; Li S; Donabedian A; Cioce V; Warf T; Huebner R
Expert Rev Vaccines; 2011 Aug; 10(8):1183-94. PubMed ID: 21854311
[TBL] [Abstract][Full Text] [Related]
18. Prospects for controlling future pandemics of influenza.
Robertson JS; Inglis SC
Virus Res; 2011 Dec; 162(1-2):39-46. PubMed ID: 21963676
[TBL] [Abstract][Full Text] [Related]
19. Improving influenza vaccines.
Sambhara S; Rappuoli R
Expert Rev Vaccines; 2012 Aug; 11(8):871-2. PubMed ID: 23002964
[No Abstract] [Full Text] [Related]
20. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
